Remed Co.,Ltd. (KOSDAQ:302550)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,750.00
+35.00 (1.29%)
At close: Aug 24, 2026

Remed Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
27,05224,50525,55418,53621,36320,195
Other Revenue
-0--0---0
27,05224,50525,55418,53621,36320,195
Revenue Growth
10.52%-4.11%37.86%-13.23%5.79%21.41%
Cost of Revenue
11,95710,54211,5089,58910,2939,880
Gross Profit
15,09513,96314,0468,94711,07110,315
Selling, General & Admin
8,9578,7738,4227,9496,5935,711
Research & Development
3,0163,2863,4832,9402,4262,731
Amortization of Goodwill & Intangibles
69.286.3297.7198.7390.8971.99
Other Operating Expenses
65.2356.7593.3897.188.4753.18
Operating Expenses
13,14213,23712,92511,8079,4109,192
Operating Income
1,953725.841,121-2,8601,6611,123
Interest Expense
-760.15-876.57-1,174-1,244-966.8-775.51
Interest & Investment Income
202.49283.1444.54847.53687.73706.26
Earnings From Equity Investments
---105.74-150.16-111.99-100.22
Currency Exchange Gain (Loss)
723.1-116.8668.74334.91272.88542.56
Other Non Operating Income (Expenses)
-664.92-125.823,304-283.263,424-576.44
EBT Excluding Unusual Items
1,454-110.254,259-3,3554,967919.81
Impairment of Goodwill
---268.88---
Gain (Loss) on Sale of Investments
30.9-57.18-343.93342.47-336.6-
Gain (Loss) on Sale of Assets
-77.46-97.84,400-0.01-70.63-36.72
Other Unusual Items
-34.13-34.13-3,992--
Pretax Income
1,373-299.358,045979.664,560883.08
Income Tax Expense
119.81-263.88664.59660.41608.71130.75
Earnings From Continuing Operations
1,253-35.477,381319.243,951752.33
Minority Interest in Earnings
797.24561.66-208.68477.9248.88-
Net Income
2,050526.27,172797.174,000752.33
Net Income to Common
2,050526.27,172797.174,000752.33
Net Income Growth
-68.34%-92.66%799.69%-80.07%431.70%-
Shares Outstanding (Basic)
313131313131
Shares Outstanding (Diluted)
313132313131
Shares Change
-2.77%-4.17%4.97%-0.35%1.84%
EPS (Basic)
66.7317.07234.0026.02130.5624.64
EPS (Diluted)
47.389.00223.0026.00130.5624.60
EPS Growth
-76.46%-95.96%757.69%-80.09%430.73%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,4171,530658.572,708261.1-7,431
Free Cash Flow Per Share
45.2949.6320.4888.398.52-243.41
Gross Margin
55.80%56.98%54.97%48.27%51.82%51.08%
Operating Margin
7.22%2.96%4.39%-15.43%7.78%5.56%
Profit Margin
7.58%2.15%28.07%4.30%18.72%3.72%
Free Cash Flow Margin
5.24%6.24%2.58%14.61%1.22%-36.80%
EBITDA
3,3852,1422,399-1,9052,4171,684
EBITDA Margin
12.51%8.74%9.39%-10.28%11.31%8.34%
D&A For EBITDA
1,4321,4171,278954.51755.6560.7
EBIT
1,953725.841,121-2,8601,6611,123
EBIT Margin
7.22%2.96%4.39%-15.43%7.78%5.56%
Effective Tax Rate
8.73%-8.26%67.41%13.35%14.81%
Advertising Expenses
-861.37535.11725.79420.15299.26